Sulphinpyrazone prevents in vivo the inhibitory effect of aspirin on rat platelet cyclo-oxygenase activity.
D000818:Animals; D001095:Arachidonic Acids / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology*; D001792:Blood Platelets / Q000187:drug effects / Q000201:enzymology*; D016861:Cyclooxygenase Inhibitors; D004347:Drug Interactions; D007700:Kinetics; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D051381:Rats; D013442:Sulfinpyrazone / Q000494:pharmacology*
D001095:Arachidonic Acids; D016861:Cyclooxygenase Inhibitors; D008315:Malondialdehyde; D001241:Aspirin; D013442:Sulfinpyrazone